CHAPTER 133

House Bill No. 2365
(Amended by Chapter 157)

An Act concerning controlled substances; adding and removing certain substances in schedule I, III and IV of the uniform controlled substances act; making conforming changes to the criminal code definition of fentanyl-related controlled substances; amending K.S.A. 65-4109 and K.S.A. 21-5701, 65-4105 and 65-4111 and repealing the existing sections.

Be it enacted by the Legislature of the State of Kansas:

Section 1. K.S.A. 2025 Supp. 21-5701 is hereby amended to read as follows: 21-5701. As used in K.S.A. 21-5701 through 21-5717, and amendments thereto:

(a) “Controlled substance” means any drug, substance or immediate precursor included in any of the schedules designated in K.S.A. 65-4105, 65-4107, 65-4109, 65-4111 and 65-4113, and amendments thereto.

(b) (1) “Controlled substance analog” means a substance that is intended for human consumption, and at least one of the following:

(A) The chemical structure of the substance is substantially similar to the chemical structure of a controlled substance listed in or added to the schedules designated in K.S.A. 65-4105 or 65-4107, and amendments thereto;

(B) the substance has a stimulant, depressant or hallucinogenic effect on the central nervous system substantially similar to the stimulant, depressant or hallucinogenic effect on the central nervous system of a controlled substance included in the schedules designated in K.S.A. 65-4105 or 65-4107, and amendments thereto; or

(C) with respect to a particular individual, such individual represents or intends the substance to have a stimulant, depressant or hallucinogenic effect on the central nervous system substantially similar to the stimulant, depressant or hallucinogenic effect on the central nervous system of a controlled substance included in the schedules designated in K.S.A. 65-4105 or 65-4107, and amendments thereto.

(2) “Controlled substance analog” does not include:

(A) A controlled substance;

(B) a substance for which there is an approved new drug application; or

(C) a substance with respect to which an exemption is in effect for investigational use by a particular person under section 505 of the federal food, drug, and cosmetic act, 21 U.S.C. § 355, to the extent conduct with respect to the substance is permitted by the exemption.

(c) “Cultivate” means the planting or promotion of growth of five or more plants that contain or can produce controlled substances.

(d) “Distribute” means the actual, constructive or attempted transfer from one person to another of some item whether or not there is an agency relationship. “Distribute” includes, but is not limited to, sale, offer for sale or any act that causes some item to be transferred from one person to another. “Distribute” does not include acts of administering, dispensing or prescribing a controlled substance as authorized by the pharmacy act of the state of Kansas, the uniform controlled substances act or otherwise authorized by law.

(e) (1) “Drug” means:

(A) Substances recognized as drugs in the official United States pharmacopeia, official homeopathic pharmacopoeia of the United States or official national formulary or any supplement to any of them;

(B) substances intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease in humans or animals;

(C) substances, other than food, intended to affect the structure or any function of the body of humans or animals; and

(D) substances intended for use as a component of any article specified in subparagraph (A), (B) or (C).

(2) “Drug” does not include devices or their components, parts or accessories.

(f) (1) “Drug paraphernalia” means all equipment and materials of any kind that are used, or primarily intended or designed for use in planting, propagating, cultivating, growing, harvesting, manufacturing, compounding, converting, producing, processing, preparing, testing, analyzing, packaging, repackaging, storing, containing, concealing, injecting, ingesting, inhaling or otherwise introducing into the human body a controlled substance and in violation of this act.

(2) “Drug paraphernalia” includes, but is not limited to:

(A) Kits used or intended for use in planting, propagating, cultivating, growing or harvesting any species of plant that is a controlled substance or from which a controlled substance can be derived;

(B) kits used or intended for use in manufacturing, compounding, converting, producing, processing or preparing controlled substances;

(C) isomerization devices used or intended for use in increasing the potency of any species of plant that is a controlled substance;

(D) testing equipment used or intended for use in identifying or in analyzing the strength, effectiveness or purity of controlled substances;

(E) scales and balances used or intended for use in weighing or measuring controlled substances;

(F) diluents and adulterants, including, but not limited to, quinine hydrochloride, mannitol, mannite, dextrose and lactose that are used or intended for use in cutting controlled substances;

(G) separation gins and sifters used or intended for use in removing twigs and seeds from or otherwise cleaning or refining marijuana;

(H) blenders, bowls, containers, spoons and mixing devices used or intended for use in compounding controlled substances;

(I) capsules, balloons, envelopes, bags and other containers used or intended for use in packaging small quantities of controlled substances;

(J) containers and other objects used or intended for use in storing or concealing controlled substances;

(K) hypodermic syringes, needles and other objects used or intended for use in parenterally injecting controlled substances into the human body;

(L) objects used or primarily intended or designed for use in ingesting, inhaling or otherwise introducing marijuana, cocaine, hashish, hashish oil, phencyclidine (PCP), methamphetamine or amphetamine into the human body, such as:

(i) Metal, wooden, acrylic, glass, stone, plastic or ceramic pipes with or without screens, permanent screens, hashish heads or punctured metal bowls;

(ii) water pipes, bongs or smoking pipes designed to draw smoke through water or another cooling device;

(iii) carburetion pipes, glass or other heat-resistant tubes or any other device used, intended to be used or designed to be used to cause vaporization of a controlled substance for inhalation;

(iv) smoking and carburetion masks;

(v) roach clips, objects used to hold burning material, such as a marijuana cigarette, that has become too small or too short to be held in the hand;

(vi) miniature cocaine spoons and cocaine vials;

(vii) chamber smoking pipes;

(viii) carburetor smoking pipes;

(ix) electric smoking pipes;

(x) air-driven smoking pipes;

(xi) chillums;

(xii) bongs;

(xiii) ice pipes or chillers;

(xiv) any smoking pipe manufactured to disguise its intended purpose;

(xv) wired cigarette papers; or

(xvi) cocaine freebase kits.

(3) “Drug paraphernalia” does not include:

(A) Any products, chemicals or materials described in K.S.A. 21-5709(a), and amendments thereto; or

(B) any materials used or intended for use to test a substance for the presence of fentanyl, a fentanyl analog, ketamine or gamma hydroxybutyric acid.

(g) “Fentanyl-related controlled substance” means any substance designated in K.S.A. 65-4105(b)(1), (b)(2), (b)(4), (b)(10), (b)(11), (b)(12), (b)(15), (b)(16), (b)(17), (b)(20), (b)(21), (b)(24), (b)(26), (b)(27), (b)(28), (b)(35), (b)(42), (b)(43), (b)(44), (b)(45), (b)(48), (b)(50), (b)(54), (b)(55), (b)(56), (b)(57), (b)(58), (b)(59), (b)(68), (b)(70), (b)(71), (b)(72), (b)(73), (b)(74), (b)(75), (b)(76), (b)(77), (b)(78), (b)(79), (b)(80), (b)(81), (b)(82), (b)(83), (b)(84), (b)(85), (b)(91), (b)(97), (b)(98), (b)(99), (b)(103), (b)(104) (b)(66), (g)(1) or, (g)(2), (i) or 65-4107(c)(1), (c)(6), (c)(9), (c)(26), (c)(28), (c)(30), (f)(3)(A) or (f)(3)(B), and amendments thereto, or any analog thereof.

(h) “Immediate precursor” means a substance that the state board of pharmacy has found to be and by rules and regulations designates as being the principal compound commonly used or produced primarily for use and that is an immediate chemical intermediary used or likely to be used in the manufacture of a controlled substance, the control of which is necessary to prevent, curtail or limit manufacture.

(i) “Isomer” means all enantiomers and diastereomers.

(j) “Manufacture” means the production, preparation, propagation, compounding, conversion or processing of or placing into pill or capsule form a controlled substance either directly or indirectly or by extraction from substances of natural origin or independently by means of chemical synthesis or by a combination of extraction and chemical synthesis. “Manufacture” does not include:

(1) The preparation or compounding of a controlled substance by an individual for the individual’s own lawful use or the preparation, compounding, packaging or labeling of a controlled substance:

(A) By a practitioner or the practitioner’s agent pursuant to a lawful order of a practitioner as an incident to the practitioner’s administering or dispensing of a controlled substance in the course of the practitioner’s professional practice; or

(B) by a practitioner or by the practitioner’s authorized agent under such practitioner’s supervision for the purpose of or as an incident to research, teaching or chemical analysis or by a pharmacist or medical care facility as an incident to dispensing of a controlled substance; or

(2) the addition of diluents or adulterants, including, but not limited to, quinine hydrochloride, mannitol, mannite, dextrose or lactose that are intended for use in cutting a controlled substance.

(k) “Marijuana” means all parts of all varieties of the plant Cannabis whether growing or not, the seeds thereof, the resin extracted from any part of the plant and every compound, manufacture, salt, derivative, mixture or preparation of the plant, its seeds or resin. “Marijuana” does not include:

(1) The mature stalks of the plant, fiber produced from the stalks, oil or cake made from the seeds of the plant, any other compound, manufacture, salt, derivative, mixture or preparation of the mature stalks, except the resin extracted therefrom, fiber, oil or cake or the sterilized seed of the plant that is incapable of germination;

(2) any substance listed in schedules II through V of the uniform controlled substances act;

(3) drug products approved by the United States food and drug administration as of the effective date of this act;

(4) cannabidiol (other trade name: 2-[(3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol); or

(5) industrial hemp as defined in K.S.A. 2-3901, and amendments thereto, when cultivated, produced, possessed or used for activities authorized by the commercial industrial hemp act.

(l) “Minor” means a person under 18 years of age.

(m) “Narcotic drug” means any of the following whether produced directly or indirectly by extraction from substances of vegetable origin or independently by means of chemical synthesis or by a combination of extraction and chemical synthesis:

(1) Opium and opiate and any salt, compound, derivative or preparation of opium or opiate;

(2) any salt, compound, isomer, derivative or preparation thereof that is chemically equivalent or identical with any of the substances referred to in paragraph (1) but not including the isoquinoline alkaloids of opium;

(3) opium poppy and poppy straw;

(4) coca leaves and any salt, compound, derivative or preparation of coca leaves and any salt, compound, isomer, derivative or preparation thereof that is chemically equivalent or identical with any of these substances, but not including decocainized coca leaves or extractions of coca leaves that do not contain cocaine or ecgonine.

(n) “Opiate” means any substance having an addiction-forming or addiction-sustaining liability similar to morphine or being capable of conversion into a drug having addiction-forming or addiction-sustaining liability. “Opiate” does not include, unless specifically designated as controlled under K.S.A. 65-4102, and amendments thereto, the dextrorotatory isomer of 3-methoxy-n-methylmorphinan and its salts (dextromethorphan). “Opiate” does include its racemic and levorotatory forms.

(o) “Opium poppy” means the plant of the species Papaver somniferum l. except its seeds.

(p) “Person” means an individual, corporation, government or governmental subdivision or agency, business trust, estate, trust, partnership, association or any other legal entity.

(q) “Poppy straw” means all parts, except the seeds, of the opium poppy, after mowing.

(r) “School property” means property upon which is located a structure used by a unified school district or an accredited nonpublic school for student instruction or attendance or extracurricular activities of pupils enrolled in kindergarten or any of the grades one through 12. This definition shall not be construed as requiring that school be in session or that classes are actually being held at the time of the offense or that children must be present within the structure or on the property during the time of any alleged criminal act. If the structure or property meets the above definition, the actual use of that structure or property at the time alleged shall not be a defense to the crime charged or the sentence imposed.

(s) “Simulated controlled substance” means any product that identifies itself by a common name or slang term associated with a controlled substance and that indicates on its label or accompanying promotional material that the product simulates the effect of a controlled substance.

Sec. 2. K.S.A. 2025 Supp. 65-4105 is hereby amended to read as follows: 65-4105. (a) The controlled substances listed in this section are included in schedule I and the number set forth opposite each drug or substance is the DEA controlled substances code that has been assigned to it.

(b) Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters and ethers, unless specifically excepted, whenever the existence of these isomers, esters, ethers and salts is possible within the specific chemical designation:

(1)	Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) 9821
(2)	Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide) 9815
(3)	Acetylmethadol 9601
(4)	Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide; acryloylfentanyl) 9811
(5)(2)	AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide) 9551
(6)(3)	Allylprodine 9602
(7)(4)	Alphacetylmethadol 9603 (except levo-alphacetylmethadol also known as levo-alpha-acetylmethadol, levomethadyl acetate or LAAM)
(8)(5)	Alphameprodine 9604
(9)(6)	Alphamethadol 9605
(10)	Alpha′-methyl butyryl fentanyl (2-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide) 9864
(11)	Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine) 9814
(12)	Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide) 9832
(13)(7)	Benzethidine 9606
(14)(8)	Betacetylmethadol 9607
(15)	Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide) 9830
(16)	Beta-hydroxy-3-methylfentanyl (other name: N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide) 9831
(17)	Beta-hydroxythiofentanyl (N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide) 9836
(18)(9)	Betameprodine 9608
(19)(10)	Betamethadol 9609
(20)	Beta-methyl fentanyl (N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)propionamide; also known as β-methyl fentanyl) 9856
(21)	Beta′-phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N, 3-diphenylpropanamide; also known as β′-phenyl fentanyl; 3-phenylpropanoyl fentanyl) 9842
(22)(11)	Betaprodine 9611
(23)(12)	Brorphine (1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one) 9098
(24)(13)	Butonitazene (2-(2-(4-butoxybenzyl)-5-nitro-1 H -benzimidazol-1-yl)- N,N -diethylethan-1-amine 9751
	Butyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide) 9822
(25)(14)	Clonitazene 9612
(26)	Crotonyl fentanyl ((E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide) 9844
(27)	Cyclopentyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide) 9847
(28)	Cyclopropyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide) 9845
(29)(15)	Dextromoramide 9613
(30)(16)	Diampromide 9615
(31)(17)	Diethylthiambutene 9616
(32)(18)	Difenoxin 9168
(33)(19)	Dimenoxadol 9617
(34)(20)	Dimepheptanol 9618
(35)	2′,5′-Dimethoxyfentanyl (N-(1-(2,5-dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide) 9861
(36)(21)	Dimethylthiambutene 9619
(37)(22)	Dioxaphetyl butyrate 9621
(38)(23)	Dipipanone 9622
(39)(24)	2-(2-(4-ethoxybenzyl)-1 H -benzimidazol-1-yl)- N,N -diethylethan-1-amine (Other names: etodesnitazene; etazene) 9765
(25)	2-(4-ethoxybenzyl)-5-nitro-1-(2-(piperidin-1-yl)ethyl)-1 H -benzimidazole (Other names: N -piperidinyl etonitazene; etonitazepipne) 9761
(26)	2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1 H -benzimidazole (Other names: N -pyrrolidino etonitazene; etonitazepyne) 9758
(27)	Ethylmethylthiambutene 9623
(40)(28)	Etonitazene 9624
(41)(29)	Etoxeridine 9625
(42)	Fentanyl carbamate (ethyl (1-phenethylpiperidin-4-yl)(phenyl)carbamate) 9851
(43)	2′-Fluoro ortho-fluorofentanyl (N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)propionamide; also known as 2′-fluoro 2-fluorofentanyl) 9855
(44)(30)	Flunitazene ( N,N -diethyl-2-(2-(4-fluorobenzyl)-5-nitro-1 H -benzimidazol-1-yl)ethan-1-amine) 9756
	Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) 9834
(45)	3-Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-3-carboxamide) 9860
(46)(31)	Furethidine 9626
(47)(32)	7-hydroxymitragynine (7-OH)
(33)	Hydroxypethidine 9627
(48)	Isobutyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide) 9827
(49)(34)	Isotonitazene (N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine; N,N-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1 H-benzimidazole-1-ethanamine 9614
(50)	Isovaleryl fentanyl (3-methyl- N -(1-phenethylpiperidin-4-yl)-N-phenylbutanamide) 9862
(51)(35)	Ketobemidone 9628
(52)(36)	Levomoramide 9629
(53)(37)	Levophenacylmorphan 9631
(54)	Meta -Fluorofentanyl (N -(3-fluorophenyl)- N-(1-phenethylpiperidin-4-yl)propionamide) 9857
(55)	Meta -Fluoroisobutyryl fentanyl ( N -(3-fluorophenyl)- N -(1-phenethylpiperidin-4-yl)isobutyramide) 9858
(56)	Methoxyacetyl fentanyl (2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) 9825
(57)(38)	2-(4-methoxybenzyl)-5-nitro-1-(2-(pyrrolidin-;1-yl)ethyl)-1 H -benzimidazole (Other names: N -pyrrolidino metonitazene; metonitazepyne) 9762
(39)	2-Methyl AP-237 (1-(2-methyl-4-(3-phenylprop-2-en-1-yl)piperazin-1-yl)butan-1-one) 9664
	4′-Methyl acetyl fentanyl (N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide) 9819
(58)	3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide) 9813
(59)	3-Methylthiofentanyl (N-[(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide) 9833
(60)(40)	Metodesnitazene ( N,N -diethyl-2-(2-(4-methoxybenzyl)-1 H -benzimidazol-1-yl)ethan-1-amine) 9764
(41)	Metonitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine) 9757
(61)(42)	Morpheridine 9632
(62)(43)	MPPP (1-methyl-4-phenyl-4-propionoxypiperidine) 9661
(63)(44)	MT-45 (1-cychohexyl-4-(1,2-diphenylethyl)piperazine) 9560
(64)(45)	N- ethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1 H -benzimidazol-1-yl)ethan-1-amine (Other name: N -desethyl isotonitazene) 9760
(46)	N,N -diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1 H -benzimidazol-1-yl)ethan-1-amine (Other name: protonitazene) 9759
(47)	5-nitro-2-(4-propoxybenzyl)-1-(2-(pyrrolidin-1-yl)ethyl)-1 H -benzimidazole (Other names: N -pyrrolidino protonitazene; protonitazepyne) 9763
(48)	Noracymethadol 9633
(65)(49)	Norlevorphanol 9634
(66)(50)	Normethadone 9635
(67)(51)	Norpipanone 9636
(68)	Ocfentanil (N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide) 9838
(69)(52)	O-desmethyltramadol (Some trade or other names: 2-((dimethylamino)methyl-1-(3-hydroxyphenyl)cyclohexanol;3-(2-((dimethylamino)methyl)-1-hydroxycyclohexyl)phenol)
(70)	Ortho-fluoroacryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)acrylamide) 9852
(71)	Ortho-fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide; also known as 2-fluorobutyryl fentanyl) 9846
(72)	Ortho-fluorofentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide; 2-fluorofentanyl) 9816
(73)	Ortho -Fluorofuranyl fentanyl ( N -(2-fluorophenyl)- N -(1-phenethylpiperidin-4-yl)furan-2-carboxamide) 9863
(74)	(Ortho-fluoroisobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) 9853
(75)	Ortho-methyl acetylfentanyl (N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide; also known as 2-methyl acetylfentanyl) 9848
(76)	Ortho-methyl methoxyacetyl fentanyl (2-methoxy-N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide; also known as 2-methyl methoxyacetyl fentanyl) 9820
(77)	Para-chloroisobutyryl fentanyl (N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) 9826
(78)	Para-fluorobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide) 9823
(79)	Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-piperidinyl]propanamide) 9812
(80)	Para-fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide, 4-fluoroisobutyryl fentanyl) 9824
(81)	Para-fluoro furanyl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide) 9854
(82)	Para-methoxybutyryl fentanyl (N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide) 9837
(83)	Para -Methoxyfuranyl fentanyl ( N -(4-methoxyphenyl)- N -(1-phenethylpiperidin-4-yl)furan-2-carboxamide 9859
(84)	para -Methylcyclopropyl fentanyl ( N -(4-methylphenyl)- N -(1-phenethylpiperidin-4-yl)cyclopropanecarboxamide) 9865
(85)	Para-methylfentanyl (N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)propionamide; also known as 4-methylfentanyl) 9817
(86)(53)	PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine) 9663
(87)(54)	Phenadoxone 9637
(88)(55)	Phenampromide 9638
(89)(56)	Phenomorphan 9647
(90)(57)	Phenoperidine 9641
(91)	Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbenzamide; also known as benzoyl fentanyl) 9841
(92)(58)	Piritramide 9642
(93)(59)	Proheptazine 9643
(94)(60)	Properidine 9644
(95)(61)	Propiram 9649
(96)(62)	Racemoramide 9645
(97)	Tetrahydrofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide) 9843
(98)	Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-propanamide) 9835
(99)	Thiofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylthiophene-2-carboxamide; also known as 2-thiofuranyl fentanyl; thiophene fentanyl) 9839
(100)(63)	Tilidine 9750
(101)(64)	Trimeperidine 9646
(102)(65)	U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) 9547
(103)	Valeryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide) 9840
(104)(66)	Zipeprol (1-methoxy-3-[4-(2-methoxy-2-phenylethyl)piperazin-1-yl]-1-phenylpropan-2-ol) 9873

(c) Any of the following opium derivatives, their salts, isomers and salts of isomers, unless specifically excepted, whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation:

(1)	Acetorphine 9319
(2)	Acetyldihydrocodeine 9051
(3)	Benzylmorphine 9052
(4)	Codeine methylbromide 9070
(5)	Codeine-N-Oxide 9053
(6)	Cyprenorphine 9054
(7)	Desomorphine 9055
(8)	Dihydromorphine 9145
(9)	Drotebanol 9335
(10)	Etorphine (except hydrochloride salt) 9056
(11)	Heroin 9200
(12)	Hydromorphinol 9301
(13)	Methyldesorphine 9302
(14)	Methyldihydromorphine 9304
(15)	Morphine methylbromide 9305
(16)	Morphine methylsulfonate 9306
(17)	Morphine-N-Oxide 9307
(18)	Myrophine 9308
(19)	Nicocodeine 9309
(20)	Nicomorphine 9312
(21)	Normorphine 9313
(22)	Pholcodine 9314
(23)	Thebacon 9315

(d) Any material, compound, mixture or preparation that contains any quantity of the following hallucinogenic substances, their salts, isomers and salts of isomers, unless specifically excepted, whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation:

(1)	Alpha-ethyltryptamine 7249
	Some trade or other names: etryptamine; Monase; α-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole; α-ET; and AET.
(2)	4-bromo-2,5-dimethoxy-amphetamine 7391
	Some trade or other names: 4-bromo-2,5-dimethoxy-alpha-methylphenethylamine; 4-bromo-2,5-DMA.
(3)	2,5-dimethoxyamphetamine 7396
	Some trade or other names: 2,5-dimethoxy-alpha-methyl-phenethylamine; 2,5-DMA.
(4)	4-methoxyamphetamine 7411
	Some trade or other names: 4-methoxy-alpha-methylphene-thylamine; paramethoxyamphetamine; PMA.
(5)	5-methoxy-3,4-methylenedioxy-amphetamine 7401
(6)	4-methyl-2,5-dimethoxy-amphetamine 7395
	Some trade or other names: 4-methyl-2,5-dimethoxy-alpha-methylphenethylamine; “DOM”; and “STP”.
(7)	3,4-methylenedioxy amphetamine 7400
(8)	3,4-methylenedioxymethamphetamine (MDMA) 7405
(9)	3,4-methylenedioxy-N-ethylamphetamine (also known as N-ethyl-alpha-methyl-3,4 (methylenedioxy) phenethylamine, N-ethyl MDA, MDE, and MDEA) 7404
(10)	N-hydroxy-3,4-methylenedioxyamphetamine (also known as N-hydroxy-alpha-methyl-3,4-(methylenedioxy) phenethylamine, and N-hydroxy MDA) 7402
(11)	3,4,5-trimethoxy amphetamine 7390
(12)	Bufotenine 7433
	Some trade or other names: 3-(Beta-Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N, N-dimethylserotonin; 5-hydroxy-N,N-dimethyltryptamine; mappine.
(13)	Diethyltryptamine 7434
	Some trade or other names: N,N-Diethyltryptamine; DET.
(14)	Dimethyltryptamine 7435
	Some trade or other names: DMT.
(15)	Ibogaine 7260
	Some trade or other names: 7-Ethyl-6,6 Beta,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido[1’,2’:1,2]azepino[5,4-b]indole; Tabernanthe iboga
(16)	Lysergic acid diethylamide 7315
(17)	Marijuana 7360
(18)	Mescaline 7381
(19)	Parahexyl 7374
	Some trade or other names: 3-Hexyl-l-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran; Synhexyl.
(20)	Peyote 7415
	Meaning all parts of the plant presently classified botanically as Lophophora williamsii Lemaire, whether growing or not, the seeds thereof, any extract from any part of such plant, and every compound, manufacture, salts, derivative, mixture or preparation of such plant, its seeds or extracts.
(21)	N-ethyl-3-piperidyl benzilate 7482
(22)	N-methyl-3-piperidyl benzilate 7484
(23)	Psilocybin 7437
(24)	Psilocyn 7438
	Some trade or other names: Psilocin.
(25)	Ethylamine analog of phencyclidine 7455
	Some trade or other names: N-ethyl-1-phenyl-cyclo-hexylamine; (1-phenylcyclohexyl)ethylamine; N-(1-phenylcyclohexyl)ethylamine; cyclohexamine; PCE.
(26)	Pyrrolidine analog of phencyclidine 7458
	Some trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine; PCPy; PHP.
(27)	Thiophene analog of phencyclidine 7470
	Some trade or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine; 2-thienyl analog of phencyclidine; TPCP; TCP.
(28)	1-[1-(2-thienyl)-cyclohexyl] pyrrolidine 7473
	Some other names: TCPy.
(29)	2,5-dimethoxy-4-ethylamphetamine 7399
	Some trade or other names: DOET.
(30)	Salvia divinorum or salvinorum A; all parts of the plant presently classified botanically as salvia divinorum, whether growing or not, the seeds thereof, any extract from any part of such plant, and every compound, manufacture, salts, derivative, mixture or preparation of such plant, its seeds or extracts.
(31)	Datura stramonium, commonly known as gypsum weed or jimson weed; all parts of the plant presently classified botanically as datura stramonium, whether growing or not, the seeds thereof, any extract from any part of such plant, and every compound, manufacture, salts, derivative, mixture or preparation of such plant, its seeds or extracts.
(32)	1-(3-[trifluoromethylphenyl])piperazine Some trade or other names: TFMPP.
(33)	4-Bromo-2,5-dimethoxyphenethylamine 7392
(34)	2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7), its optical isomers, salts and salts of optical isomers 7348
(35)	Alpha-methyltryptamine (other name: AMT) 7432
(36)	5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT), its isomers, salts and salts of isomers 7439
(37)	2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E) 7509
(38)	2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D) 7508
(39)	2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C) 7519
(40)	2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I) 7518
(41)	2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2) 7385
(42)	2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4) 7532
(43)	2-(2,5-Dimethoxyphenyl)ethanamine (2C-H) 7517
(44)	2-(2,5-Dimethoxy-4-nitrophenyl)ethanamine (2C-N) 7521
(45)	2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P) 7524
(46)	5–methoxy–N,N–dimethyltryptamine (5–MeO–DMT) 7431
	Some trade or other names: 5–methoxy–3–[2–(dimethylamino) ethyl]indole.
(47)	2–(4–iodo–2,5–dimethoxyphenyl)–N–(2–methoxybenzyl)ethanamine 7538
	Some trade or other names: 25I–NBOMe; 2C–I–NBOMe; 25I; Cimbi–5.
(48)	2–(4–chloro–2,5–dimethoxyphenyl)–N–(2–methoxybenzyl)ethanamine 7537
	Some trade or other names: 25C–NBOMe; 2C–C–NBOMe; 25C; Cimbi–82.
(49)	2–(4–bromo–2,5–dimethoxyphenyl)–N–(2–methoxybenzyl)ethanamine 7536
	Some trade or other names: 25B–NBOMe; 2C–B–NBOMe; 25B; Cimbi–36.
(50)	2-(2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine Some trade or other names: 25H-NBOMe.
(51)	2-(2,5-dimethoxy-4-methylphenyl)-N-(2-methoxybenzyl)ethanamine Some trade or other names: 25D-NBOMe; 2C-D-NBOMe.
(52)	2-(2,5-dimethoxy-4-nitrophenyl)-N-(2-methoxybenzyl)ethanamine Some trade or other names: 25N-NBOMe, 2C-N-NBOMe.
(53)	1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1 H-pyrrolo[2,3-b]pyridine-3-carboxamide (5F-CUMYL-P7AICA) 7085
(54)	2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one (other names: methoxetamine, MXE) 7286
(55)	1-(4-methoxyphenyl)-N-methylpropan-2-amine (other names: para-methoxymethamphetamine, PMMA 1245

(e) Any material, compound, mixture or preparation that contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

(1)	Etizolam 2780
	Some trade or other names: (4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine)
(2)	Mecloqualone 2572
(3)	Methaqualone 2565
(4)	Gamma hydroxybutyric acid 2010
(5)	8-chloro-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine, its salts, isomers, and salts of isomers (other name: flualprazolam) 2785
(6)	6-(2-chlorophenyl)-1-methyl-8-nitro-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine, its salts, isomers, and salts of isomers (other name: clonazolam) 2786
(7)	8-bromo-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine, its salts, isomers, and salts of isomers (other name: flubromazolam) 2788
(8)	7-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one, its salts, isomers, and salts of isomers (other name: diclazepam) 2789

(f) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation that contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers and salts of isomers:

(1)	Aminorex 1585
	Some other names: Aminoxaphen 2-amino-5-phenyl-2-oxazoline or 4,5-dihydro-5-phenyl-2-oxazolamine
(2)	Fenethylline 1503
(3)	N-ethylamphetamine 1475
(4)	(+)cis-4-methylaminorex ((+)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine) 1590
(5)	N,N-dimethylamphetamine (also known as N,N-alpha-trimethyl-benzeneethanamine; N,N-alpha-trimethylphenethylamine) 1480
(6)	Cathinone (some other names: 2-amino-1-phenol-1-propanone, alpha-amino propiophenone, 2-amino propiophenone and norphedrone) 1235
(7)	Substituted cathinones Any compound, except bupropion or compounds listed under a different schedule, structurally derived from 2–aminopropan–1–one by substitution at the 1-position with either phenyl, naphthyl, or thiophene ring systems, whether or not the compound is further modified in any of the following ways:
	(A) By substitution in the ring system to any extent with alkyl, alkylenedioxy, alkoxy, haloalkyl, hydroxyl, or halide substituents, whether or not further substituted in the ring system by one or more other univalent substituents;
	(B) by substitution at the 3-position with an acyclic alkyl substituent;
	(C) by substitution at the 2-amino nitrogen atom with alkyl, dialkyl, benzyl, or methoxybenzyl groups; or
	(D) by inclusion of the 2-amino nitrogen atom in a cyclic structure.
(8)	N-benzylpiperazine (other names: BZP, 1-benzylpiprazine) 7493
(9)	Methiopropamine (N-methyl-1-(thiophen-2-yl)propan-2-amine) 1478
(10)	4,4′-Dimethylaminorex (4,4′-DMAR; 4,5-dihydro-4-methyl-5-(4-methylphenyl)-2-oxazolamine; 4-methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine) 1595
(11)	Amineptine (7-[(10,11-dihydro-5 H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid) 1219
(12)	Mesocarb (N-phenyl-N ′-(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium-5-yl)carbamimidate) 1227
(13)	Ethylphenidate (ethyl 2-phenyl-2-(piperidin-2-yl)acetate) 1727

(g) Any material, compound, mixture or preparation that contains any quantity of the following substances:

(1)	N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl), its optical isomers, salts and salts of isomers
(2)	N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl), its optical isomers, salts and salts of isomers
(3)	Tianeptine, its optical isomers, salts and salts of isomers

(h) Any of the following cannabinoids, their salts, isomers and salts of isomers, unless specifically excepted, whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation:

(1)

Tetrahydrocannabinols 7370

Meaning tetrahydrocannabinols naturally contained in a ;plant of the genus Cannabis (cannabis plant), as well as synthetic equivalents of the substances contained in the plant, or in the resinous extractives of Cannabis, sp. and/or synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity such as the following: Delta 1 9 cis or trans tetrahydrocannabinol, and their optical isomers Delta 6 8 cis or trans tetrahydrocannabinol, and their optical isomers Delta 3,4 6a,10a cis or trans tetrahydrocannabinol, and its optical isomers (Since nomenclature of these substances is not internationally standardized, compounds of these structures, regardless of numerical designation of atomic positions covered.), except tetrahydrocannabinols in any of the following:

(A) Industrial hemp, as defined in K.S.A. 2-3901, and amendments thereto;

(B) solid waste, as defined in K.S.A. 65-3402, and amendments thereto, and hazardous waste, as defined in K.S.A. 65-3430, and amendments thereto, if such waste is the result of the cultivation, production or processing of industrial hemp, as defined in K.S.A. 2-3901, and amendments thereto, and such waste contains a delta-9 tetrahydrocannabinol concentration of not more than 0.3%; or

(C) hemp products, as defined in K.S.A. 2-3901, and amendments thereto, unless otherwise deemed unlawful pursuant to K.S.A. 2-3908, and amendments thereto.

For the purposes of this subsection, the dibenzopyran system is the numbering convention used to identify the carbon atoms of the chemical structure.

(2)	Naphthylmethylindoles Any compound containing a 1H-indol-3-yl-(1-naphthyl)methane structure with substitution at the nitrogen atom of the indole group by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group whether or not further substituted on the indole group to any extent and whether or not substituted on the benzyl or naphthyl ring to any extent.
(3)	Naphthoylpyrroles Any compound containing a 3-(1-naphthoyl)pyrrole structure with substitution at the nitrogen atom of the pyrrole group by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group whether or not further substituted on the pyrrole group to any extent, whether or not substituted on the benzyl or naphthyl ring to any extent.
(4)	Naphthylmethylindenes Any compound containing a naphthylmethylindene structure with substitution at the 3-position of the indene group by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group whether or not further substituted on the indene group to any extent, whether or not substituted on the benzyl or naphthyl ring to any extent.
(5)	Cyclohexylphenols Any compound containing a 2-(3-hydroxycyclohexyl)phenol structure with substitution at the 5-position of the phenolic ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group whether or not substituted on the cyclohexyl ring to any extent.
(6)	2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-napthalenylmethanone. Some trade or other names: WIN 55,212-2.
(7)	9-(hydroxymethyl)-6, 6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol Some trade or other names: HU-210, HU-211.
(8)	Indole-3-carboxylate esters Any compound containing a 1H-indole-3-carboxylate ester structure with the ester oxygen bearing a naphthyl, quinolinyl, isoquinolinyl or adamantyl group and substitution at the 1 position of the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted on the indole ring to any extent and whether or not substituted on the naphthyl, quinolinyl, isoquinolinyl, adamantyl or benzyl groups to any extent.
(9)	Indazole-3-carboxamides Any compound containing a 1H-indazole-3-carboxamide structure with substitution at the nitrogen of the carboxamide by a naphthyl, quinolinyl, isoquinolinyl, adamantyl, benzyl, 1-amino-1-oxoalkan-2-yl or 1-alkoxy-1-oxoalkan-2-yl group and substitution at the 1 position of the indazole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted on the indazole ring to any extent and whether or not substituted on the naphthyl, quinolinyl, isoquinolinyl, adamantyl, 1-amino-1-oxoalkan-2-yl, 1-alkoxy-1-oxoalkan-2-yl or benzyl groups to any extent.
(10)	Indole-3-carboxamides Any compound containing a 1H-indole-3-carboxamide structure with substitution at the nitrogen of the carboxamide by a naphthyl, quinolinyl, isoquinolinyl, adamantyl, benzyl, 1-amino-1-oxoalkan-2-yl or 1-alkoxy-1-oxoalkan-2-yl group and substitution at the 1 position of the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted on the indole ring to any extent and whether or not further substituted on the naphthyl, quinolinyl, isoquinolinyl, adamantyl, 1-amino-1-oxoalkan-2-yl, 1-alkoxy-1-oxoalkan-2-yl or benzyl groups to any extent.
(11)	(1H-indazol-3-yl)methanones Any compound containing a (1H-indazol-3-yl)methanone structure with the carbonyl carbon bearing a naphthyl group and substitution at the 1 position of the indazole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted on the indazole ring to any extent and whether or not substituted on the naphthyl or benzyl groups to any extent.
(12)	(1H-indol-3-yl)methanones Any compound containing a (1H-indol-3-yl)methanone structure with the carbonyl carbon bearing a naphthyl, quinolinyl, isoquinolinyl, adamantyl, phenyl, benzyl or tetramethylcyclopropyl group and substitution at the 1 position of the indole ring by an alkyl,haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or tetrahydropyranylmethyl group, whether or not further substituted on the indole ring to any extent and whether or not substituted on the naphthyl, quinolinyl, isoquinolinyl, adamantyl, phenyl, benzyl or tetramethylcyclopropyl groups to any extent.
(13)	Hexahydrocannabinol (HHC)
(14)	5-Pentyl-2-(2-phenylpropan-2-yl)pyrido[4,3-b]indol-1-one, its optical and geometric isomers, salts and salts of isomers (Some trade or other names: CUMYL–PEGACLONE; SGT–151) 7093

(i) (1) Unless specifically exempted or unless listed in schedules II through V of the uniform controlled substances act, any material, compound, mixture or preparation that contains any quantity of a fentanyl-related substance or that contains the salts, isomers and salts of isomers of a fentanyl-related substance whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation.

(2) “Fentanyl-related substance” means any substance that is structurally related to fentanyl by one or more of the following modifications:

(A) Replacement of the phenyl portion of the phenethyl group by any monocycle, whether or not further substituted in or on the monocycle;

(B) substitution in or on the phenethyl group (or replacement as described in sub-paragraph (A)) with alkyl, alkenyl, alkoxyl, hydroxyl, halo, haloalkyl, amino or nitro groups;

(C) substitution in or on the piperidine ring with alkyl, alkenyl, alkoxyl, ester, ether, hydroxyl, halo, haloalkyl, amino or nitro groups;

(D) replacement of the aniline ring with any aromatic monocycle whether or not further substituted in or on the aromatic monocycle; or

(E) replacement of the N-propionyl group by another acyl group.

Sec. 3. K.S.A. 65-4109 is hereby amended to read as follows: 65-4109. (a) The controlled substances listed in this section are included in schedule III and the number set forth opposite each drug or substance is the DEA controlled substances code which has been assigned to it.

(b) Unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a potential for abuse associated with a depressant effect on the central nervous system:

(1)	Any compound, mixture or preparation containing:
(A)	Amobarbital 2126
(B)	Secobarbital 2316
(C)	Pentobarbital 2271
	or any salt thereof and one or more other active medicinal ingredients which are not listed in any schedule.
(2)	Any suppository dosage form containing:
(A)	Amobarbital 2126
(B)	Secobarbital 2316
(C)	Pentobarbital 2271
	or any salt of any of these drugs and approved by the Food and Drug Administration for marketing only as a suppository.
(3)	Any substance which contains any quantity of a derivative of barbituric acid, or any salt of a derivative of barbituric acid, except those substances which are specifically listed in other schedules 2100
(4)	Chlorhexadol 2510
(5)	Lysergic acid 7300
(6)	Lysergic acid amide 7310
(7)	Methyprylon 2575
(8)	Sulfondiethylmethane 2600
(9)	Sulfonethylmethane 2605
(10)	Sulfonmethane 2610
(11)	Tiletamine and zolazepam or any salt thereof 7295
	Some trade or other names for a tiletamine-zolazepam combination product: Telazol Some trade or other names for tiletamine: 2-(ethylamino)-2-(2-thienyl)-cyclohexanone Some trade or other names for zolazepam: 4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-e][1,4]-diazepin-7(1H)-one, flupyrazapon
(12)	Ketamine, its salts, isomers, and salts of isomers 7285
	Some other names for ketamine: (±)-2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone
(13)	Gamma hydroxybutyric acid, any salt, hydroxybutyric compound, derivative or preparation of gamma hydroxybutyric acid contained in a drug product for which an application has been approved under section 505 of the federal food, drug and cosmetic act
(14)	Embutramide 2020
(15)	Perampanel, its salts, isomers, and salts of isomers 2261
	Some other names for perampanel: 2-(2-oxo-1-phenyl-5-pyridin-2-yl-1,2 dihydropyridin-3-yl) benzonitrile
(c)	Nalorphine 9400

(d) Any material, compound, mixture or preparation containing any of the following narcotic drugs or any salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below:

(1)	Not more than 1.8 grams of codeine or any of its salts per 100 milliliters or not more than 90 milligrams per dosage unit with an equal or greater quantity of an isoquinoline alkaloid of opium 9803
(2)	not more than 1.8 grams of codeine or any of its salts per 100 milliliters or not more than 90 milligrams per dosage unit with one or more active, nonnarcotic ingredients in recognized therapeutic amounts 9804
(3)	not more than 1.8 grams of dihydrocodeine or any of its salts per 100 milliliters or not more than 90 milligrams per dosage unit with one or more active, nonnarcotic ingredients in recognized therapeutic amounts 9807
(4)	not more than 300 milligrams of ethylmorphine or any of its salts per 100 milliliters or not more than 15 milligrams per dosage unit with one or more active, nonnarcotic ingredients in recognized therapeutic amounts 9808
(5)	not more than 500 milligrams of opium per 100 milliliters or per 100 grams or not more than 25 milligrams per dosage unit with one or more active, nonnarcotic ingredients in recognized therapeutic amounts 9809
(6)	not more than 50 milligrams of morphine or any of its salts per 100 milliliters or per 100 grams with one or more active, nonnarcotic ingredients in recognized therapeutic amounts 9810
(7)	any material, compound, mixture or preparation containing any of the following narcotic drugs or their salts, as set forth below:
(A)	Buprenorphine 9064

(e) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, position or geometric) and salts of such isomers whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation:

(1)	Those compounds, mixtures or preparations in dosage unit form containing any stimulant substance listed in schedule II, which compounds, mixtures or preparations were listed on August 25, 1971, as excepted compounds under section 308.32 of title 21 of the code of federal regulations, and any other drug of the quantitive composition shown in that list for those drugs or which is the same, except that it contains a lesser quantity of controlled substances 1405
(2)	Benzphetamine 1228
(3)	Chlorphentermine 1645
(4)	Chlortermine 1647
(5)	Phendimetrazine 1615

• (f) Anabolic steroids 4000

“Anabolic steroid” means any drug or hormonal substance, chemically and pharmacologically related to testosterone (other than estrogens, progestins, and corticosteroids) that promotes muscle growth, and includes:

(1)	3β,17-dihydroxy-5a-androstane
(2)	3α,17β-dihydroxy-5a-androstane
(3)	5α-androstan-3,17-dione
(4)	1-androstenediol (3β,17β-dihydroxy-5α-androst-1-ene)
(5)	1-androstenediol (3α,17β-dihydroxy-5α-androst-1-ene)
(6)	4-androstenediol (3β,17β-dihydroxy-androst-4-ene)
(7)	5-androstenediol (3β,17β-dihydroxy-androst-5-ene)
(8)	1-androstenedione ([5α]-androst-1-en-3,17-dione)
(9)	4-androstenedione (androst-4-en-3,17-dione)
(10)	5-androstenedione (androst-5-en-3,17-dione)
(11)	bolasterone (7α,17α-dimethyl-17β-hydroxyandrost-4-en-3-one)
(12)	boldenone (17β-hydroxyandrost-1,4-diene-3-one)
(13)	boldione (androsta-1,4-diene-3,17-dione)
(14)	calusterone (7β,17α-dimethyl-17β-hydroxyandrost-4-en-3-one)
(15)	clostebol (4-chloro-17β-hydroxyandrost-4-en-3-one)
(16)	dehydrochloromethyltestosterone (4-chloro-17β-hydroxy-17α-methyl-androst-1,4-dien-3-one)
(17)	desoxymethyltestosterone (17α-methyl-5α-androst-2-en-17β-ol) (also known as “madol”)
(18)	Δ1-dihydrotestosterone (17β-hydroxy-5α-androst-1-en-3-one) (also known as “1-testosterone”)
(19)	4-dihydrotestosterone (17β-hydroxy-androstan-3-one)
(20)	drostanolone (17β-hydroxy-2α-methyl-5α-androstan-3-one)
(21)	ethylestrenol (17α-ethyl-17β-hydroxyestr-4-ene)
(22)	fluoxymesterone (9-fluoro-17α-methyl-11β,17β-dihydroxyandrost-4-en-3-one)
(23)	formebolone (2-formyl-17α-methyl-11α,17β-dihydroxyandrost-1,4-dien-3-one)
(24)	furazabol (17α-methyl-17β-hydroxyandrostano[2,3-c]-furazan)
(25)	13β-ethyl-17β-hydroxygon-4-en-3-one
(26)	4-hydroxytestosterone (4,17β-dihydroxy-androst-4-en-3-one)
(27)	4-hydroxy-19-nortestosterone (4,17β-dihydroxy-estr-4-en-3-one)
(28)	mestanolone (17α-methyl-17β-hydroxy-5-androstan-3-one)
(29)	mesterolone (1α-methyl-17β-hydroxy-[5α]-androstan-3-one)
(30)	methandienone (17α-methyl-17β-hydroxyandrost-1,4-dien-3-one)
(31)	methandriol (17α-methyl-3β,17β-dihydroxyandrost-5-ene)
(32)	methasterone (2α,17α-dimethyl-5α-androstan-17β-ol-3-one)
(33)	methenolone (1-methyl-17β-hydroxy-5α-androst-1-en-3-one)
(34)	17α-methyl-3β,17β-dihydroxy-5a-androstane
(35)	17α-methyl-3α,17β-dihydroxy-5a-androstane
(36)	17α-methyl-3β,17β-dihydroxyandrost-4-ene
(37)	17α-methyl-4-hydroxynandrolone (17α-methyl-4-hydroxy-17β-hydroxyestr-4-en-3-one)
(38)	methyldienolone (17α-methyl-17β-hydroxyestra-4,9(10)-dien-3-one)
(39)	methyltrienolone (17α-methyl-17β-hydroxyestra-4,9,11-trien-3-one)
(40)	methyltestosterone (17α-methyl-17β-hydroxyandrost-4-en-3-one)
(41)	mibolerone (7α,17α-dimethyl-17β-hydroxyestr-4-en-3-one)
(42)	17α-methyl-Δ1-dihydrotestosterone (17β-hydroxy-17α-methyl-5α-androst-1-en-3-one) (also known as “17-α-methyl-1-testosterone”)
(43)	nandrolone (17β-hydroxyestr-4-en-3-one)
(44)	19-nor-4-androstenediol (3β, 17β-dihydroxyestr-4-ene)
(45)	19-nor-4-androstenediol (3α, 17β-dihydroxyestr-4-ene)
(46)	19-nor-5-androstenediol (3β, 17β-dihydroxyestr-5-ene)
(47)	19-nor-5-androstenediol (3α, 17β-dihydroxyestr-5-ene)
(48)	19-nor-4,9(10)-androstadienedione (estra-4,9(10)-diene-3,17-dione)
(49)	19-nor-4-androstenedione (estr-4-en-3,17-dione)
(50)	19-nor-5-androstenedione (estr-5-en-3,17-dione)
(51)	norbolethone (13β, 17α-diethyl-17β-hydroxygon-4-en-3-one)
(52)	norclostebol (4-chloro-17β-hydroxyestr-4-en-3-one)
(53)	norethandrolone (17α-ethyl-17β-hydroxyestr-4-en-3-one)
(54)	normethandrolone (17α-methyl-17β-hydroxyestr-4-en-3-one)
(55)	oxandrolone (17α-methyl-17β-hydroxy-2-oxa-[5α]-androstan-3-one)
(56)	oxymesterone (17α-methyl-4,17β-dihydroxyandrost-4-en-3-one)
(57)	oxymetholone (17α-methyl-2-hydroxymethylene-17β-hydroxy-[5α]-androstan-3-one)
(58)	prostanozol (17β-hydroxy-5α-androstano[3,2-c]pyrazole)
(59)	stanozolol (17α-methyl-17β-hydroxy-[5α]-androst-2-eno[3,2-c]-pyrazole)
(60)	stenbolone (17β-hydroxy-2-methyl-[5α]-androst-1-en-3-one)
(61)	testolactone (13-hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid lactone)
(62)	testosterone (17β-hydroxyandrost-4-en-3-one)
(63)	tetrahydrogestrinone (13β, 17α-diethyl-17β-hydroxygon-4,9,11-trien-3-one)
(64)	trenbolone (17β-hydroxyestr-4,9,11-trien-3-one)
(65)	5α-androstan-3,6,17-trione;
(66)	6-bromo-androsta-1,4-diene-3,17-dione;
(67)	6-bromo-androstan-3,17-dione;
(68)	4-chloro-17α-methyl-androsta-1,4-diene-3,17β-diol;
(69)	4-chloro-17α-methyl-androst-4-ene-3β,17β-diol;
(70)	4-chloro-17α-methyl-17β-hydroxy-androst-4-en-3-one;
(71)	4-chloro-17α-methyl-17β-hydroxy-androst-4-ene-3,11-dione;
(72)	2α,17α-dimethyl-17β-hydroxy-5β-androstan-3-one;
(73)	2α,3α-epithio-17α-methyl-5α-androstan-17β-ol;
(74)	estra-4,9,11-triene-3,17-dione;
(75)	[3,2-c]furazan-5α-androstan-17β-ol;
(76)	18a-homo-3-hydroxy-estra-2,5(10)-dien-17-one;
(77)	4-hydroxy-androst-4-ene-3,17-dione;
(78)	17β-hydroxy-androstano[2,3-d]isoxazole;
(79)	17β-hydroxy-androstano[3,2-c]isoxazole;
(80)	3β-hydroxy-estra-4,9,11-triene-17-one;
(81)	17α-methyl-androsta-1,4-diene-3,17β-diol;
(82)	17α-methyl-5α-androstan-17β-ol;
(83)	17α-methyl-androstan-3-hydroxyimine-17β-ol;
(84)	6α-methyl-androst-4-ene-3,17-dione;
(85)	17α-methyl-androst-2-ene-3,17β-diol;
(86)	[3,2-c]pyrazole-androst-4-en-17β-ol;
(87)	any salt, ester, or isomer of a drug or substance described or listed in this paragraph, if that salt, ester, or isomer promotes muscle growth.
(A)	Except as provided in (B), such term does not include an anabolic steroid which is expressly intended for administration through implants to cattle or other nonhuman species and which has been approved by the United States’ secretary of health and human services for such administration.
(B)	If any person prescribes, dispenses or distributes such steroid for human use, such person shall be considered to have prescribed, dispensed or distributed an anabolic steroid within the meaning of this subsection (f).

(g) Any material, compound, mixture or preparation which contains any quantity of the following hallucinogenic substance, its salts, isomers and salts of isomers, unless specifically excepted, whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation:

(1)	Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a United States food and drug administration approved product 7369
	Some other names for dronabinol: (6aR-trans)-6a,7,8,10a-tetrahydro-6-6-9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-0l, or (-)-delta-9-(trans)-tetrahydrocannabinol.

(h) The board may except by rule any compound, mixture or preparation containing any stimulant or depressant substance listed in subsection (b) from the application of all or any part of this act if the compound, mixture or preparation contains one or more active medicinal ingredients not having a stimulant or depressant effect on the central nervous system and if the admixtures are included therein in combinations, quantity, proportion or concentration that vitiate the potential for abuse of the substances which have a stimulant or depressant effect on the central nervous system.

Sec. 4. K.S.A. 2025 Supp. 65-4111 is hereby amended to read as follows: 65-4111. (a) The controlled substances listed in this section are included in schedule IV and the number set forth opposite each drug or substance is the DEA controlled substances code that has been assigned to it.

(b) Any material, compound, mixture or preparation that contains any quantity of the following substances including its salts, isomers and salts of isomers whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation and having a potential for abuse associated with a depressant effect on the central nervous system:

(1)	Alprazolam 2882
(2)	Barbital 2145
(3)	Brexanolone 2400
(4)	Bromazepam 2748
(5)	Camazepam 2749
(6)	Carisoprodol 8192
(7)	Chloral betaine 2460
(8)	Chloral hydrate 2465
(9)	Chlordiazepoxide 2744
(10)	Clobazam 2751
(11)	Clonazepam 2737
(12)	Clorazepate 2768
(13)	Clotiazepam 2752
(14)	Cloxazolam 2753
(15)	Daridorexant 2410
(16)	Delorazepam 2754
(17)	Diazepam 2765
(18)	Dichloralphenazone 2467
(19)	Estazolam 2756
(20)	Ethchlorvynol 2540
(21)	Ethinamate 2545
(22)	Ethyl loflazepate 2758
(23)	Fludiazepam 2759
(24)	Flunitrazepam 2763
(25)	Flurazepam 2767
(26)	Fospropofol 2138
(27)	Halazepam 2762
(28)	Haloxazolam 2771
(29)	Ketazolam 2772
(30)	Lemborexant 2245
(31)	Loprazolam 2773
(32)	Lorazepam 2885
(33)	Lormetazepam 2774
(34)	Mebutamate 2800
(35)	Medazepam 2836
(36)	Meprobamate 2820
(37)	Methohexital 2264
(38)	Methylphenobarbital (mephobarbital) 2250
(39)	Midazolam 2884
(40)	Nimetazepam 2837
(41)	Nitrazepam 2834
(42)	Nordiazepam 2838
(43)	Oxazepam 2835
(44)	Oxazolam 2839
(45)	Paraldehyde 2585
(46)	Petrichloral 2591
(47)	Phenobarbital 2285
(48)	Pinazepam 2883
(49)	Prazepam 2764
(50)	Quazepam 2881
(51)	Remimazolam 2846
(52)	Temazepam 2925
(53)	Tetrazepam 2886
(54)	Triazolam 2887
(55)	Zolpidem 2783
(56)	Zaleplon 2781
(57)	Zopiclone 2784
(58)	Alfaxalone 2731
(59)	Suvorexant 2223
(60)	Zuranolone 2420

(c) Any material, compound, mixture or preparation that contains any quantity of lorcaserin (1625), including its salts, isomers and salts of such isomers, whenever the existence of such salts, isomers and salts of isomers is possible (21 U.S.C. § 812; 21 C.F.R. § 1308.14).

(d) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation that contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, position or geometric) and salts of such isomers whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation:

(1)	Cathine ((+)-norpseudoephedrine) 1230
(2)	Diethylpropion 1610
(3)	Fencamfamin 1760
(4)	Fenproporex 1575
(5)	Mazindol 1605
(6)	Mefenorex 1580
(7)	Pemoline (including organometallic complexes and chelates thereof) 1530
(8)	Phentermine 1640
The provisions of subsection (d)(8) shall expire on the date phentermine and its salts and isomers are removed from schedule IV of the federal controlled substances act (21 U.S.C. § 812; 21 C.F.R. § 1308.14).
(9)	Pipradrol 1750
(10)	Serdexmethylphenidate 1729
(11)	SPA((-)-1-dimethylamino-1, 2-diphenylethane) 1635
(12)	Sibutramine 1675
(13)	Solriamfetol (2-amino-3-phenylpropyl carbamate; benzenepropanol, beta-amino-, carbamate (ester)) 1650
(14)	MondafinilModafinil 1680

(e) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation that contains any quantity of the following, including salts thereof:

(1)	Pentazocine 9709
(2)	Butorphanol (including its optical isomers) 9720
(3)	Eluxadoline (5-[[[(2S)-2-amino-3-[4-aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl][(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]-2-methoxybenzoic acid) (including its optical isomers) and its salts, isomers, and salts of isomers 9725

(f) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below:

(1)	Not more than 1 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit 9167
(2)	Dextropropoxyphene (alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propion-oxybutane) 9278
(3)	2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol, its salts, optical and geometric isomers and salts of these isomers (including tramadol) 9752

(g) Butyl nitrite and its salts, isomers, esters, ethers or their salts.

(h) The board may except by rule and regulation any compound, mixture or preparation containing any depressant substance listed in subsection (b) from the application of all or any part of this act if the compound, mixture or preparation contains one or more active medicinal ingredients not having a depressant effect on the central nervous system, and if the admixtures are included therein in combinations, quantity, proportion or concentration that vitiate the potential for abuse of the substances that have a depressant effect on the central nervous system.

Sec. 5 K.S.A. 65-4109 and K.S.A 2025 Supp. 21-5701, 65-4105 and 65-4111 are hereby repealed.

Sec. 6. This act shall take effect and be in force from and after its publication in the statute book.

Approved April 10, 2026.